ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: alberts elected To Second Term as NAS President

February 19, 1999

In Brief: Mark Kochevar Named New Administrative Officer Of DCE; Thomas Necheles Dies Suddenly at 51

September 21, 1984

Funding Opportunities

September 27, 2002

DeVita, Moertel Debate Timing Of Levamisole Update

February 16, 1990

St. Jude Children’s wins NCI contract for Pediatric Preclinical Testing Program.

November 12, 2004

NCI Programs: Institute To Develop Plans For Large Trial Of Spiral CT Scanning For Lung Cancer

November 5, 1999